These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30340578)

  • 1. Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection.
    Siriyong T; Voravuthikunchai SP; Coote PJ
    BMC Complement Altern Med; 2018 Oct; 18(1):285. PubMed ID: 30340578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Holarrhena antidysenterica Extract and Its Steroidal Alkaloid, Conessine, as Resistance-Modifying Agents Against Extensively Drug-Resistant Acinetobacter baumannii.
    Siriyong T; Chusri S; Srimanote P; Tipmanee V; Voravuthikunchai SP
    Microb Drug Resist; 2016 Jun; 22(4):273-82. PubMed ID: 26745443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa.
    Krezdorn J; Adams S; Coote PJ
    J Med Microbiol; 2014 Jul; 63(Pt 7):945-955. PubMed ID: 24928215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy with Ciprofloxacin and Pentamidine against Multidrug-Resistant
    Fletcher M; McCormack A; Parcell BJ; Coote PJ
    Antibiotics (Basel); 2023 Jul; 12(8):. PubMed ID: 37627656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomistic insight and modeled elucidation of conessine towards
    Jewboonchu J; Saetang J; Saeloh D; Siriyong T; Rungrotmongkol T; Voravuthikunchai SP; Tipmanee V
    J Biomol Struct Dyn; 2022 Mar; 40(4):1480-1489. PubMed ID: 33025857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa.
    Li XZ; Barré N; Poole K
    J Antimicrob Chemother; 2000 Dec; 46(6):885-93. PubMed ID: 11102405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD; Wolter DJ; Wickman PA; Reisbig MD
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
    Hill L; Veli N; Coote PJ
    Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps.
    Chusri S; Na-Phatthalung P; Siriyong T; Paosen S; Voravuthikunchai SP
    Microbiol Res; 2014; 169(5-6):417-24. PubMed ID: 24103863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
    Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of MexCD-OprJ and MexEF-OprN Efflux Systems in the Multiple Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Clinical Samples.
    Jamal Z; Gholami M; Ebrahimzadeh MA; Goli HR
    Curr Microbiol; 2023 May; 80(7):221. PubMed ID: 37210698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy?
    Griffith DC; Corcoran E; Lofland D; Lee A; Cho D; Lomovskaya O; Dudley MN
    Antimicrob Agents Chemother; 2006 May; 50(5):1628-32. PubMed ID: 16641428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-interchangeable functions of efflux transporters of
    Adamiak JW; Ajmal L; Zgurskaya HI
    J Bacteriol; 2024 Jul; 206(7):e0005424. PubMed ID: 38874367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.